Market›Health Care›Pharmaceuticals›Pharmaceuticals
DAIICHI SANKYO CO LT ADR

DSNKY

$15.56Apr 26, 2021 – Apr 24, 2026
Health CarePharmaceuticals$32.41B
MVM
+$40.4M
TD Variance
1.818

Every news event mapped to its market reaction — 46 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-10-01+8.3%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSKYF) Q2 2024 Earnings Call Transcript
2025-10-01+8.3%legalSeeking AlphaAstraZeneca, Daiichi win FDA review for Enhertu label expansion
2025-10-31-7.1%earningsSeeking AlphaDaiichi Sankyo GAAP EPS of 70.52, revenue of 975.35B; updates FY outlook
2025-10-31-7.1%earningsSeeking AlphaDaiichi Sankyo Company, Limited 2026 Q2 - Results - Earnings Call Presentation
2026-04-21-6.7%newsInsider Monkey5 Best Small-Cap Biotech Stocks According to Hedge Funds
2026-04-21-6.7%earningsMarketBeatDaiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down - What's Next? - MarketBeat
2026-01-13-6.5%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2026-01-13-6.5%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2025-09-19-6.1%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Discusses On WCLC 2025 Highlights (Transcript)
2025-09-19-6.1%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Special Call - Slideshow
2025-04-25+5.2%newsStock TitanUCBJY Stock Price, News & Analysis - Stock Titan
2026-04-14+4.8%legalZacksMRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
2026-04-14+4.8%newsBusiness Wire4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
2026-04-22-4.4%newsInsider MonkeyNuvation Bio (NUVB) Stock More Than Doubles Year-on-Year
2026-01-29-3.9%earningsInvesting.comExxon, Chevron, American Express, and more to report earnings Friday - Investing.com
2025-06-02-3.9%newsSeeking AlphaAstraZeneca says Enhertu, Perjeta combo cuts death risk in breast cancer
2025-04-24+3.6%newsStock TitanRHHBY Stock Price, News & Analysis | Roche Hldg - Stock Titan
2026-04-17+3.6%newsSimply Wall St.Merck’s Priority Review Cancer Drug Adds To Undervalued Growth Story
2026-04-15+3.4%legalPR NewswireWayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase
2025-12-15+3.3%newsSeeking AlphaAstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval
2026-02-02+3.1%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Q3 FY2025 Earnings Call Transcript
2026-04-13-2.9%legalSimply Wall St.FDA Priority Review And New Alliances Reshape Daiichi Sankyo Growth Story
2026-04-13-2.9%newsSimply Wall St.Assessing Daiichi Sankyo (TSE:4568) Valuation After A Year Of Weak Share Price Returns
2026-04-13-2.9%earningsMarketBeatDaiichi Sankyo (OTCMKTS:DSNKY) Sets New 52-Week Low - Here's Why - MarketBeat
2025-09-26-2.7%newsSeeking AlphaTrumps 100% drug tariffs send pharma stocks lower
2025-07-31+2.5%earningsSeeking AlphaDaiichi Sankyo reports Q1 results
2025-07-17+2.4%newsSeeking AlphaAstraZeneca, Daiichi Sankyo get U.S. breakthrough therapy status for Enhertu
2026-04-20-2.0%newsBusiness WireDana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
2026-01-30-2.0%earningsSeeking AlphaDaiichi Sankyo GAAP EPS of 117.28, revenue of 1533.46B; reaffirms FY outlook
2025-10-21-1.9%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions Transcript
2025-10-21-1.9%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions - Slideshow
2026-04-01+1.4%newsSeeking AlphaNuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo
2025-01-09-1.2%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) - Zacks Investment Research
2025-12-16-1.2%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day Transcript
2025-12-16-1.2%newsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day - Slideshow
2026-04-16-1.1%newsPR NewswireInterna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies
2025-12-09-0.9%newsSeeking AlphaDaiichi Sankyo: Pressing The ADC Case Further, Not Being Felt By The Market
2025-08-11-0.9%legalSeeking AlphaViatris wins FDA nod for generic iron sucrose injection targeting Daiichis Venofer
2025-10-18+0.7%newsSeeking AlphaAstra, Daiichi post late-stage data to show Enhertus potential in early breast cancer
2026-02-24+0.7%newsSeeking AlphaDaiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued
2026-03-14-0.6%earningsSeeking AlphaHighest and lowest quant-rated healthcare stocks above $10B cap after earnings season
2026-02-03-0.6%legalSeeking AlphaAstra wins FDA priority review for Daiichis Datroway; denied approval for lupus therapy
2025-08-01+0.4%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSKYF) Q1 FY2025 Earnings Call Transcript
2025-11-06-0.3%earningsSeeking AlphaDaiichi Sankyo Company, Limited (DSNKY) Q2 FY2025 Earnings Call Transcript
2025-11-12-0.1%newsSeeking AlphaDaiichi Sankyo partnering with General Proximity on oncology targets
2025-06-24-0.0%newsSeeking AlphaDaiichi Sankyo, AstraZeneca gets U.S. approval for Datroway
tickerdossier.comtickerdossier.substack.com